Germline degradation of a mouse model of familial amyotrophic lateral sclerosis when breeding

Chinese Journal of Tissue Engineering Research

Volumn 17, Issue 24, 2013, Pages 4521-4528

  Cai, Bin ^a   Fan, Dong sheng ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

Amyotrophic lateral sclerosis; Basic experiments in tissue construction; Breeding; Germline deterioration; Morbid animal model; National Natural Science Foundation of China; Tissue construction; Transgenic mouse

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREEDING; CONTROLLED STUDY; FAMILIAL DISEASE; FEMALE; FEMALE FERTILITY; GERM LINE; LITTER SIZE; MALE; MOUSE; MOUSE MODEL; NONHUMAN; PATHOGENESIS; TRANSGENIC MOUSE;

EID: 84922687132     PISSN: 16738225     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.2095-4344.2013.24.022     Document Type: Article

References (43)

1. Pratt AJ, Getzoff ED, Perry JJ. Amyotrophic lateral sclerosis: update and new developments. Degener Neurol Neuromuscul Dis.2012;2012(2):1-14.
2. Benkler C, Offen D, Melamed E, et al. Recent advances in amyotrophic lateral sclerosis research: perspectives for personalized clinical application. EPMA J.2010;1(2): 343-361.
3. Venkova-Hristova K, Christov A, Kamaluddin Z, et al. Progress in therapy development for amyotrophic lateral sclerosis. Neurol Res Int. 2012;2012:187234.
4. Naganska E, Matyja E. Amyotrophic lateral sclerosis-looking for pathogenesis and effective therapy. Folia Neuropathol.2011;49(1):1-13.
5. Thonhoff JR, Ojeda L, Wu P. Stem cell-derived motor neurons: applications and challenges in amyotrophic lateral sclerosis. Curr Stem Cell Res Ther. 2009;4(3): 178-199.
6. Hefferan MP, Galik J, Kakinohana O, et al. Human neural stem cell replacement therapy for amyotrophic lateral sclerosis by spinal transplantation. PLoS One.2012;7(8): e42614.
7. Wang DB, Gitcho MA, Kraemer BC, et al. Genetic strategies to study TDP-43 in rodents and to develop preclinical therapeutics for amyotrophic lateral sclerosis. Eur J Neurosci. 2011;34(8):1179-1188.
8. Rosen DR. Mutations in CuZn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature.1993;362:59-62.
9. Turner BJ, Talbot K. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS. Prog Neurobiol.2008;85(1):94-134.
10. Julien J. Mouse models of amyotrophic lateralsclerosis. Drug Discovery Today: Disease Models. 2006;3(4):331-339.
11. Mali Y, Zisapel N. A novel decoy that interrupts G93A-superoxide dismutase gain of interaction with malate dehydrogenase improves survival in an amyotrophic lateral sclerosis cell model. J Med Chem. 2009;52(17):5442-5448.
12. Koh SH, Lee YB, Kim KS, et al. Role of GSK-3beta activity in motor neuronal cell death induced by G93A or A4V mutant hSOD1 gene. Eur J Neurosci. 2005;22(2):301-309.
13. Gurney ME, Pu H, Chiu AY. moter neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science. 1994;5166(264):1772-1775.
14. Joyce PI, Fratta P, Fisher EM, et al. SOD1 and TDP-43 animal models of amyotrophic lateral sclerosis: recent advances in understanding disease toward the development of clinical treatments. Mamm Genome.2011;22(7-8):420-448.
15. Rj M, Ej B, Aj K, et al. Optimised and Rapid Pre-clinical Screening in the SOD1G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis (ALS). Plos One. 2011;6(8): e23244.
16. Huang H, Zhang C, Xi J, et al. Nanfang Yike Daxue Xuebao. 2006;26(3):258-260.
17. Guo YS, Yu JX, Duan WS, et al. Nao yu Shenjing Jibing Zazhi.
18. Henriques A, Pitzer C, Schneider A. Characterization of a novel SOD-1(G93A) transgenic mouse line with very decelerated disease development]. PLoS One. 2010;5(11):e15445.
19. Qian Y, Ye BQ, Geng JG, et al. Shiyan Dongwu yu Bijiao Yixue. 2009;29(2):124-126.
20. Alves C J, de Santana L P, Dos S A, et al. Early motor and electrophysiological changes in transgenic mouse model of amyotrophic lateral sclerosis and gender differences on clinical outcome. Brain Res. 2011;1394:90-104.
21. Bame M, Pentiak P A, Needleman R, et al. Effect of Sex on Lifespan, Disease Progression, and the Response to Methionine Sulfoximine in the SOD1 G93A Mouse Model for ALS. Gend Med. 2012;9(6):524-535.
22. Herron LR, Miles GB. Gender-specific perturbations in modulatory inputs to motoneurons in a mouse model of amyotrophic lateral sclerosis. Neuroscience. 2012;226:313-323.
23. Huisman MH, de Jong SW, van Doormaal PT, et al. Population based epidemiology of amyotrophic lateral sclerosis using capture-recapture methodology. J Neurol Neurosurg Psychiatry. 2011;82(10):1165-1170.
24. Manjaly ZR, Scott KM, Abhinav K, et al. The sex ratio in amyotrophic lateral sclerosis: A population based study. Amyotroph Lateral Scler.2010;11(5):439-442.
25. Miller RG, Anderson FJ, Bradley WG, et al. The ALS patient care database: goals, design, and early results. ALS C.A.R.E. Study Group. Neurology. 2000;54(1):53-57.
26. Choi CI, Lee YD, Gwag BJ, et al. Effects of estrogen on lifespan and motor functions in female hSOD1 G93A transgenic mice. J Neurol Sci. 2008;268(1-2):40-47.
27. Bromberg M B. Pathogenesis of amyotrophic lateral sclerosis: a critical review. Curr Opin Neurol.1999;12(5):581-588.
28. de Jong S, Huisman M, Sutedja N, et al. Endogenous female reproductive hormones and the risk of amyotrophic lateral sclerosis. J Neurol. 2013;260(2):507-512.
29. Czlonkowska A, Ciesielska A, Gromadzka G, et al. Estrogen and cytokines production-the possible cause of gender differences in neurological diseases. Curr Pharm Des. 2005; 11(8):1017-1030.
30. Popat RA, Van Den Eeden SK, Tanner CM, et al. Effect of reproductive factors and postmenopausal hormone use on the risk of amyotrophic lateral sclerosis. Neuroepidemiology. 2006;27(3):117-121.
31. Xiao AQ. Shengwuxue Jiaoxue. 2009;34(4):69.
32. Günther R, Suhr M, Koch JC, et al. linical testing and spinal cord removal in a mouse model for amyotrophic lateral sclerosis (ALS). J Vis Exp. 2012;(61). pii: 3936.
33. Knippenberg S, Thau N, Dengler R, et al. Significance of behavioural tests in a transgenic mouse model of amyotrophic lateral sclerosis (ALS). Behav Brain Res. 2010;213(1):82-87.
34. Kafkafi N, Yekutieli D, Yarowsky P, et al. Data mining in a behavioral test detects early symptoms in a model of amyotrophic lateral sclerosis. Behav Neurosci. 2008;122(4): 777-787.
35. Lu SX, Mao HM, Lu LG, et al. Jiangsu Nongye Xuebao. 2009; 25(5):991-996.
36. Tonsor S J. Population genomics and the causes of local differentiation[J]. Mol Ecol. 2012;21(22):5393-5395.
37. Willi Y, Griffin P, Van Buskirk J. Drift load in populations of small size and low density. Heredity (Edinb). 2013;110(3): 296-302.
38. Niemann H, Lucas-Hahn A. Somatic cell nuclear transfer cloning: practical applications and current legislation. Reprod Domest Anim. 2012;47 Suppl 5:2-10.
39. Zheng S, Geghman K, Shenoy S, et al. Retake the center stage--new development of rat genetics. J Genet Genomics. 2012;39(6):261-268.
40. Devoy A, Bunton-Stasyshyn R K, Tybulewicz V L, et al. Genomically humanized mice: technologies and promises. Nat Rev Genet. 2012;13(1):14-20.
41. Xu P, Liu LJ, Yu LL, et al. Zhongguo Bijiao Yixue Zazhi. 2009; 19(8):9-14.
42. Saragusty J, Arav A. Current progress in oocyte and embryo cryopreservation by slow freezing and vitrification. Reproduction. 2011;141(1):1-19.
43. Leibo SP. Cryopreservation of oocytes and embryos: optimization by theoretical versus empirical analysis. Theriogenology. 2008;69(1):37-47.